1154415-17-4

Upstream product

• 933585-10-5 (3-bromo-4-chlorophenyl) acetate 
• 13659-24-0 3-bromo-4-chlorophenol 
• 2732-80-1 2-bromo-1-chloro-4-methoxybenzene 
• 75-36-5 acetyl chloride 

Downstream Products

• 1154415-19-6 C₁₄H₁₉ClN₂O₂ 
• 1154415-20-9 C₁₁H₁₄ClNO₃ 
• 1154415-18-5 C₁₃H₁₆ClNO₃ 
• 1462921-15-8 4-acetyl-6-chloro-3-hydroxy-2-iodobenzonitrile 
• 1462921-16-9 tert-butyl [2-(6-acetyl-4-chloro-3-cyano-2-iodophenoxy)ethyl]carbamate 
• 1462921-17-0 tert-butyl [2-(6-acetyl-4-chloro-3-cyano-2-vinylphenoxy)ethyl]carbamate 
• 1462921-18-1 tert-butyl {2-[4-chloro-3-cyano-6-(1-hydroxyethyl)-2-vinylphenoxy]ethyl}carbamate 
• 1462921-19-2 tert-butyl {2-[4-chloro-3-cyano-2-formyl-6-(1-hydroxyethyl)phenoxy]ethyl}carbamate 
• 1462921-14-7 4-acetyl-2-chloro-5-hydroxybenzonitrile 

Relevant academic research and scientific papers

PYRIDINE DERIVATIVES AS TMEM16A MODULATORS FOR USE IN THE TREATMENT OF RESPIRATORY CONDITIONS

Compounds of general formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are as defined herein are useful for treating respiratory di

BICYCLIC AZAHETEROCYCLOBENZYLAMINES AS PI3K INHIBITORS

The present invention provides bicyclic azaheterocyclobenzylamines of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity

EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS

The present invention is related to novel compounds of formula (I) having equilibrative nucleoside transporter ENTl inhibiting properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the inhibition of ENTl receptors in animals, in particular humans.